Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	534.65	491.73	398.2	214.2	140.83	119.07
Revenue Growth (YoY)	29.97%	23.49%	85.90%	52.10%	18.27%	16.39%
Cost of Revenue	88.19	81.49	145.12	54.18	38.82	33.54
Gross Profit	446.46	410.24	253.09	160.02	102.01	85.54
Selling, General & Admin	177.71	177.74	133.71	57.09	49.63	44.23
Operating Expenses	215.09	215.12	166.28	58.18	49.63	44.23
Operating Income	231.37	195.12	86.81	101.84	52.39	41.3
Interest & Investment Income	18.23	16.06	4.68	-	0.28	0.59
Other Non Operating Income (Expenses)	-	-	-	2.88	-	-
EBT Excluding Unusual Items	249.6	211.19	91.49	104.72	52.67	41.89
Gain (Loss) on Sale of Investments	8.86	5.08	3.02	-	-	-
Pretax Income	258.46	216.26	94.51	104.72	52.67	41.89
Income Tax Expense	61.11	52.37	23.1	21.64	13.19	-33.09
Net Income	197.35	163.89	71.41	83.08	39.48	74.98
Net Income to Common	197.35	163.89	71.41	83.08	39.48	74.98
Net Income Growth	203.07%	129.50%	-14.05%	110.42%	-47.34%	135.24%
Shares Outstanding (Basic)	120	118	106	103	103	104
Shares Outstanding (Diluted)	126	125	114	111	108	106
Shares Change (YoY)	8.38%	9.84%	2.14%	3.32%	1.46%	0.21%
EPS (Basic)	1.65	1.38	0.67	0.80	0.38	0.72
EPS (Diluted)	1.57	1.31	0.63	0.75	0.37	0.71
EPS Growth	178.13%	107.94%	-16.00%	102.70%	-47.89%	136.67%
Free Cash Flow	267.57	239.25	-54.92	106.02	59.35	45.02
Free Cash Flow Per Share	2.13	1.92	-0.48	0.95	0.55	0.42
Gross Margin	83.50%	83.43%	63.56%	74.70%	72.44%	71.84%
Operating Margin	43.27%	39.68%	21.80%	47.54%	37.20%	34.69%
Profit Margin	36.91%	33.33%	17.93%	38.78%	28.04%	62.97%
Free Cash Flow Margin	50.05%	48.66%	-13.79%	49.49%	42.14%	37.81%
EBITDA	269.17	232.9	119.69	103.08	52.58	41.4
EBITDA Margin	50.34%	47.36%	30.06%	48.12%	37.33%	34.76%
D&A For EBITDA	37.8	37.77	32.88	1.24	0.19	0.09
EBIT	231.37	195.12	86.81	101.84	52.39	41.3
EBIT Margin	43.27%	39.68%	21.80%	47.54%	37.20%	34.69%
Effective Tax Rate	23.64%	24.22%	24.44%	20.66%	25.04%	-
Revenue as Reported	534.65	491.73	398.2	214.2	140.83	119.07
Advertising Expenses	-	10	9.1	3.3	2.9	2.5

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q